CA1144604A - Iontophoretic treatment apparatus - Google Patents

Iontophoretic treatment apparatus

Info

Publication number
CA1144604A
CA1144604A CA000345403A CA345403A CA1144604A CA 1144604 A CA1144604 A CA 1144604A CA 000345403 A CA000345403 A CA 000345403A CA 345403 A CA345403 A CA 345403A CA 1144604 A CA1144604 A CA 1144604A
Authority
CA
Canada
Prior art keywords
electrodes
treatment
support structure
iontophoretic
pads
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000345403A
Other languages
French (fr)
Inventor
Robert Tapper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1144604A publication Critical patent/CA1144604A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432Anode and cathode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432Anode and cathode
    • A61N1/0436Material of the electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432Anode and cathode
    • A61N1/044Shape of the electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details

Abstract

IONTOPHORETIC TREATMENT APPARATUS

ABSTRACT
This invention relates to a device for conven-iently effecting iontophoretic treatment of the surface of the human body. Prior art devices for the iontophor-etic treatment of parts of the body such as the hands or feet have the undesirable effect of causing the treatment current to flow through parts of the body not being treated. Further, iontophoretic treatment devices known heretofore have been cumbersome and awkward to use, and could only be used by trained medical personnel who had to supervise the administration of the treatment of a patient. The present invention overcomes these defi-ciencies by providing a self-contained iontophoretic treatment apparatus which includes a support structure on which is mounted a pair of electrodes in generally close proximity to one another as well as a source of electrical power and appropriate controls for delivering electrical power to the electrodes. me electrodes are arranged so that, for example, the palm of a single human hand can be placed on the device and simultaneously contact both electrodes, thereby confining the ionto-phonetic treatment to the palm surface of the hand.
Alternative embodiments of the invention specially adapted for treating the plantar surfaces of the feet and the axillae are also disclosed.

Description

IONTOP}I~R~TIG TREAT~ENT ~PPARATUS

~ECHNI~AL FIELD
This inventi~rl relates generally to medical treatment devices, and, more particularly, to a device for conveniently effecting iontophoretic treatment Or the surface of the h~man body.
BACKGROUND OF THE P_IOR ART
Iontophoretic treatments have been popular in the past for their polar effects on ~onized molecules, causing the ionized molecules to be driven through the skin, usually superficially, This phenomenon has been employed, ~or example, for the ~ntroduct~on of medlcants, or even simply moisture, into the skin o~ a patient.
In other applications of iontophoretic treat-mentæ, some ions of zinc and copper can be employed in the treatment of some skin infections, and chlorine ions have been employed for the loosening o~ superficial scars. Further, vasodilatlng drugs can be used in rheumatic and peripheral vasc~lar a~ections, and skln anesthetic drugs. It has been suggested that applica-tion o~ direct current to care~ully selected areas of a living animal can product anesthetic effects. (See Limoge, An introduction to Electroanesthesia, 1975, University Park Press). In still another application o~ iontophoretic treatment, it has been suggested that iontuph~resis can be employed to e~fect mass hair removal from the treated area.
F. Levitt in "Archives of Dermatology", Vol. 98 No. 5, November 1968, reports on pps. 505-7 the produc-tion of long term anhidrosis ~y electric treatment o~
the feet, or hands. However, he disclosed ~nly the use o~ "a two-inch square o~ sheet lead" as an electrode.
~his is "p~aced in a shallow pan oontaining enough water 3~ to ~ust cover the palm or soles"; there being one elec-trode and ~e pan for each palm or sole. ~s test re~ults indicate that the treatment inhibits perspira-tlon (sweat) where the electric current is provided.
It will be noted that, although this arrangement provldes for the de~lred lontophoretic treatment ~ the .

11 ~460~

hands or feet, it has the undesirable effect of causing the treatment current to flow through parts of the body not be~ng treated That is, when this arrangement is being employed for treating a patient's hands, for ex-ample, the treatment current flows from one hand to theother through the pat~ent~s torso. This can have the undesirable effect of disrupting the normal function of vital body organs or interfering with artificial devlces associated with the body, such as an electronic pace-10 maker, or the like.
From the foregoing, it wlll be appreciated thatit is hlghly desirable to be able to adminieter conven-iently iontophoretic treatment to a patient, and it ls particularly desirable for a person who desires ionto-phoretic treatment to be able to safely and convenientlyadminister that treatment to himself. Moreovcr, it is very desirable to confine the iontophoretic treatment only to the area Or the body being treated ln order to avoid unnecessarily disrupting the normal functi~n of 20 vital body organs or any arti~ic1al devices associated therewith.
As mentioned above, iontophoretic treatment devices known heretofore have been cumbersome ~nd ~wkward to use, and could only be useo by trained medical per-25 sonnel who had to supervise the administration of thetreatment o~ a patient. These devices frequently in-cluded wires leading to electrodes which were difflcult to hold in place during the treatment. Moreo~er, the patient frequently had to be placed in an uncomfortable and inconvenient situation during the treatment, such ~s holding hls hands or feet in pans of water, whlch further discouraged use oY iontophoretic treatment by the medical commun~ty. ~astly, iontophoretlc treatment devices which employed a pair of electrodes of the same or very simllar metals have been sub~ect to corrosion o~ those electrodes which results ln a loss of current over the period of treatment thereby decreasing the effectivenese of the treatment.
Accord~ngly~ there has existed a need ~or a 60~

convenient and effectlve ~evice ~or adminlsterln~ lon-tophoretic treatn~nt to the surface of the human body, whlch device can be easil~- and sa~ely used by the person on whom the treatment is ~eing effec~ed, and whlch device confines the treatment current to the area of the body being treated and which is capable of maintaining the treatment current at a relatively high level through-out a normal treatment period. As wiil become apparent from the ~ollowin~, the present invent on satisfies those need~-~RIEF S UMMARY OF THE INVENTION
.
The present invention resides in a new and improved apparatus for effecting iontoph~retic treatment to the su~face of a human body, which apparatus can ~e used safely and convenlently by the person being treated and which may cause the treatment current to flow only through the portion of the body being treated. More_ over, the iontophoretic treatment apparatus of this lnvention is relativel-y inexpensive to manufacture, is trouble ~ree and reliable in use, and is capable of sus.
taining a relatively high level of treatment current over a long period o~ treatment.
More specifically, the preferred embodiments of this inventlon are ~pecially adapted for admini~tering iontophoretic treatment to the palm surface o~ a human hand, the plantar surface of a human ~oot and the axilla areas of the body. For these purposesj three distinct embodiments are provided.
The first embodiment, which ls designed for 3 treat~n~ the palm o~ a hand, is a sel~-contalned, uni-tary de~ice which ~neludes an upper sur~acP sized to correspond generally to the slze of a human hand. Two electrodes are dlsposed on the upper sur~ace in gener-ally close proxlmity to one another and are separated ~y 3~ a narrow ~nsulating member. Further, a manual control 8witch ls also located on the upper sur ace. With th~s arrangement, a user can simply place hls hand palm down on the upper surface of the devlce, extending across the insulating member and slmultaneously c ontac ting both Q-~

electrodes. ~'J simple manual operation of the switch, as with 'he thumb, the user can activat~ the device and thereby easlly and conven~ently administer iontophoretic treatment to himsel~.
The second embodiment is specially adapted for admlnistering iontophoretic treatment to the plantar surface of a foot. This embodiment is similar to the first embod~mént but is longer and can be narrower to accommodate the shape of a human foot. Further, an arched portion is built into the device along one side and generally at the center thereof. This arched por-tion assures contact with the arched portion of the plantar surface of a foot. Also, a control switch can be located on the side of the device for easy manual operatlon.
The third embodiment is substantially different in construction from the first and second embodiments, and is ~pecially adapted for permitting iontophoretic treatment o~ the axilla portions or armpit areas of the body. To accommodate the contour cf the axilla portion of the body, the third embodiment of this lnventlon includes two general y parallel, oppositely facing electrodes mounted on a single unitary support structure.
In order to hold this devlce ln place during treatment, the user simply positions the device ln his armpit and holds his arm down during the treatment In this way, the user's hands are free for other activlties during the iontophoretic treatment of the axilla area.
In all of the above embodiments, a stainless 3 steel electrode is preferably used for the electrode whlch læ primar~ly a cathode, and an aluminum electrode is preferably u~ed for the electrode which ls primarlly an anode. By this arrangement, a mlnlmum o~ corroslon of the electrodes will occur, and the device wlll be able ~o æustain a relatively high operating current over extended periods o~ time.
Other ~eatures and advantages of the present ~nventlon will become ~pparent from the following de-tailed description, taken in con~unctlon with the 0~,~

accompanying drawings~ l~hich illustrate, by way of ex-ample, the principles ~ the invention.
BRIEF DES~RIPTION OF ~rHE ~RAWINGS
FIGURE 1 is a perspe~tive view of an iontophoretlc treatmen~ device embcdying the present invention, and illustrated as arranged for treatment of the palm of a human hand, and havlng portions thereof broken away to reveal parts not ordinarily visible;
FIG. 2 is an enlarged, fragmentary view, partly ln sectlon, of the devlce illustrated in FIG. 1, and taken substantially along line 2-2 of FIG. l;
FIG. 3 is a fragmentary top view of a manual control which is provided on the device illustDated in FIG. 1;
FIG. 4 is a perspective view of an alternatlve embodiment of the iontophoretic treatment device of this invention, illustrated as arranged for treating the plantar surface of a human foot, and shown with certa~n parts broken away to reveal parta not ord1narily visible.
FIG. 5 is a perspective view of another alter-native embodiment o~ the iontophoretic treatment device of this lnvention, illustrated as arranged for treating the axilla area of a body, and having a portion broken away to show a detail of the construction thereof;
FIG. ~a is an enlarged view of the portion o~ the end of the devlce enclosed within the arrow 5a in FIG.
5;
FIG. 6 is an enlarged, fragmentary view, partly in section, showing an arrangement for retention o~
electrode pads wh~ch can be used with the device illus-trated in ~IG. ~;
FIG. 7 is a perspective view o~ the pad reta~ner shown in FIG. 6; ~nd FIG. 8 ls a top view of the pad retainer, taken 5 generally in the direction of the arrow ~ in FIG. ~.
DETAIIED DESCRIPTION OF THE INVENTION
As shown ln the exemplary drawings, the present invention i s embodied in an iontophoreti~ treat~ent apparatus, lndicated generally by reference number 10 O~

in FIa. 1, and having a palr of electrodes 12 and 14 ror effecting iontoph~retic treatment. The apparatus 10 includes a source of electrical power, such as a battery 16 (FIG 2), which is connected to a suitable control device 18 that in turn is connected to the electrodes 12 and 14.
The control dev~ce 18 can include a manual con-trol switch 20 for activating and deactivating the ap-paratus 10, and if desired, the switch 20 can lnclude a continuous control device, such as a potentiometer, to permlt manual control o~ the level of treatment current admin1stered by the apparatus 10. Further, each of the electrodes 12 and 14 is provlded with a moisture ab-3 orbing pad 22 and 24 to be interpo~ed between the sur-~ace being treated and the electrodes 12 an~ 14 respec-tively to ensure adequate electrical contact wlth the surface to be treated and to distribute that electrical contact over a greater area of the treated surface.
In accordance with the present invention, an lontophoretic treatment device is provided which ls self-contained and includes a pair of electrodes 12 and 14 mounted on a slngle support structure 26 ln gener-ally clo~e proximity to ~ne another and ~eparated by a relatlvely narrow ~nsulating member 28. The support structure 26 also houses the s~urce of electrical power 16 and the control device 18 for controlling the dellvery of electrical power to the electrodes. The electrodes 12 and 14 are mounted close enough to one another to permit the surface to be treated, ~or example, the palm ~urface of Q human hand, to extend across the insulating member 28 and simultaneously contact both electr~des.
With thls arrangement, a slngle unitary structure can be employed ~or administering lontophoretic treatment to a person, and advantageously, the treatment current 3~ 1~ confined to the area kelng treated To accomplish this desired result, the support structure 26, ln the embodlment illustrated ln FIGS. 1 and 2, ls generally rectangular~ and the electrodes 12 and 14 are mounted on the upper surface of the rectangu-;O-~

lar ~tructure 26. In this instance, the apparatus 10 is specialiy adapted for treating tlle palm surface Or a human hand, and acccrdingly the length and width of the rectangular structure is chosen to correspond generally with the size o~ a human hand.
More speci~ically/ as can b~st be seen in FIG.
2, the support structure 26 is comprised primarily of two members, an upper body member 30 and a lower cover 32. The insulæking member 28 is formed as part of the body 30 and extends across the middle thereo~ separating two upwardly facing recesses 34 and 36 in the bottom of which are recelved the electrodes 12 and 14 respectively.
The support structure 26 is preferably constructed ~
plastlc, and the lower cover 32 can simply ~nap on the 1~ body 30 to close the apparatus 10 in order to pre~ent a neat appearance and protect the contents of the apparatus.
The source of electrical power, or battery 16, i8 recei~ed in a mounting bracket 38 which ls secured to the body 32 in any suitable manner. The pair o~ elec-trlcal leads 40 supply power from the battery to the control device 18 from which power is supplied to the electrodes 12 and 14 through electrical leads 42 and 44, respectlvely. For the purpose of connectlng these leads to the electrodes, a tab 46 is bent downwardly from each electrode and extends through the bottom of the recesses 34 and 36J and the leads 42 and 44 are connected to the downwardly extending tabs 46 ln a conventional manner.
As described in greater detail in the above-mentioned patent applicat1ons, a porous intervenor ormoisture absorbing pad 22 and 24 is interposed between the electrodes 12 and 14 and the surface o~ the user to be treated. As ~urther described ln tne abo~e-mentloned ~atent applications, it ls sometimes desirable for one of these pads tv be relatively thlck while the other need not be thick~ and as can be seen from FI&. 2, provision ~or vary~ng thicknesses in the pads 22 and 24 can easlly be made in the apparatus 10 o~ the present lnvention by Yarying the depth Or the recesses 3~ and 36.

tl~t;O-~

Wh~ e ~ads ~ nd 24 ale used, it ls gener-ally desirable to keep them moist in order to facllitate conduction of electrici~ tnrough the pads. In order to best rctain the mois~ e w~thin the pads, the recesses 34 and 36 are p--eferably water-tight and serve as reser-voirs ~or retention ol~ molslure in the pads. To best serve this purpose, the apertures in the bottom of the recesses through whlch the tabs 46 extend are preferably sealed in any conventional manner after the eiectrodes have been installed.
To prevent inadvertent short c~rcuiting of the apparatus 10 when in use, the insulating member 28 ex-tends transversely across the apparatus between the recesses 34 and 36 and is o~ sufficient height to separ-ate the pads 22 and 24. Moreover, in order to ensurethat no moisture ~rom the pads can flow across the lnsulating member 28 and cause a short circuit~ the member 28 preferably includes a series f upstanding rlbs ~8 whlch also extcnd ~ran~versely across the apparatus 10.
While the ~ads 22 and 2~ can be of any suitable porous materlal, it has been ~ound that a polyester material ls preferrcd. For exampleJ ~olyester electrode pads soak up ~ater much more rea.dlly than do pads made o~ wool felt used hereto~ore, and polyester pads do not exhibit the tendency to sh-rink which is present ln wool pads. Moreover, pol~ester ~ads are much more economical to supply~ and do not support bacterlal li~e as readily as wool felt pads.
It has also been found that by using the same or similar metals for both electrodes in an iontophoretic treatment device, which h;s been the common practice hereto~ore, a substantial lo~s of current ~s experienced over the treatment period due to corrosion occurring on one or both of the electrodes. For example, in an iontophoretlc treatment device ~n which both the anode and cathode are aluminum alloy, a signi~icant loss o~
current i~ experienced over ea^h treatment period, and each ~uccessive treatment period beghins at the level o~

60 ~

103~ experienced at the end of the preceding period.
Naturally, a~ter several treatinent periods~ the ionto-phoretic treatment device ~ill have lost its effective-ness.
In contrast to this, it has been found that by using a stainless steel electrode as the cathode of the iontophoretic device and an electrode of substantlally pure aluminum, such as that available under the commer-cial designation ALCOA 1100, as the anode, a loss of current of only about six to eight percent occurs over approximately the first one-half hour of treatment, and vlrtually no losses occur t~lereafter. Moreover, the devlce returns to full power at the beginning of each sub~equent treatment.
As can best be seen in FIG. 3, the control ~wltch 20 is preferably a continuous control device, such as a potentiometer, to permit the user to ad~ust the level of iontophoretic treatment being admlnistered.
This ~acilltates the utility of the apparatus 10 for use in the home by the person being treated since it permit~ the user to select the level of treatment per-sonally desired, Further, a light 50 can be provided ad~acent to the switch 20 to indicate whether the appar-atu~ 10 1~ activated An alternative embodiment of the present lnven-tion, illu~trated as an iontophoretic treat~ent device 52 ln FIG. 4, is speclally adapted for treating the plantar surface of a single foot For this purpose, the con~iguration of the support structure 53 of this device iB generally similar to the conflguration Or the support structure 26 o~ the device illustrated ln FIGS. 1 and 2.
That ~s, the device is generally rectangular, has a pair o~ electrodes 54 and 56 d~sposed on itB upper sur~ace and a narrow ~nsulating member 58 separatlng the elec-
3~ trodes 5~ and 56.
To accommodate the shape and contour o~ theplantar sur~ace o~ a ~oot, the foot device 52 iB gener-ally longer than the hand device 10, and can be slightly narrower. Further, to assure adequate contact wlth the 60'~

ent~re plantar suriace of a rOOt, particularly with the arch portion cf a hu~an fo~t, a generally arched or raised portion 60 ls pro~ided on the upper surface of the device 5', and this arched portion is centrally located on the device along one side thereof.
It is commonly believed that the amount of treatment ef~ected at each electrode is very nearly equal. Accordingly the ~oot device ~2 described herein can be used for treat~ng either the right or le~t foot by simply reversing the device end-for-end so that the arched porti~n 6C will cooperate with the arch of either a right or left foot. ~t will also be noted that a control switch 62 is provided on the side of the devlce ~2 ~or easy manual operation.
1~ A third embodiment of the present invention, ill~strated as an iontophoretic treatment device 54 in FIGS. ~ and 6, ls specially adapted for treating the axilla area of a human body. For this purpose, the support structure 66 of the device 64 is not a generally flat rectangular structure as described above, but rather is a generally upright structure having a pair of electrodes 68 and 70 (FIG. 6) in generally parallel planes and facing oppositely from one another. With this arrangement, the iontophoretic treatment device 64 can be positioned in the axilla area and held in place during treatment by the user simply lowering hls arm.
Thls arrangement has a significant advantage over prior devices in that the user's hands are relatively free during treatment~ making this device particularly conven-3 ient to use. More~ver, as in the other devices dlsclosedherein, the treatment de~ice 64 includes a control switch 72 on the body 66 for manually activating and controlling the level o~ treatment.
As with the ~ormer de~ices disclosed herein, the iontophoretic treatment device 64 employs porous pads 74 and 76 between the electrodes and the sur~ace being treatedJ and these pads are preferably to be kept moist to ~acllitate conductivity. For this purpose, as can best be seen in the cut-away portlon of FIG. 5, a water-lt~ O~

tight trough 77 is provided along the botto~, of the body66, and the lower end of t.he pad 74 e~tends into the trough. This permits the trough 77 to serve as a reser-voir for reta~ning mo~sture in the pad 74. Naturally, a second trough (not shown) can be provided on the other side of the body 66 to serve as a similar reservoir for the other pad 76.
For the purpose o~ providlng an insulating member between the electrode 68 and 70 and further for holding the pads 74 and 76 in place on the body ~6, a pad retainer 78 bears against the upper portion of the pads 74 and 76 and is releasably secured to the body 66, as will be described in greater detail below. As can best be seen in FIG. 6, the upper portion of the body 66 includes a generally U-shaped channel 80 which is divided into two channels by a vertical dividing wall 82. The upper portion of each of the pads 74 and 76 is bent over into one of the two channels, and the dividing wall 82 serves to prevent short circuitlng of the device 64 by ellmina-ting any contact between the pads 74 and 76.
To hold the pads 74 and 16 in placeJ the retainer78 includes a pair o~ longitudinally extending flanges 84 and 86 which pro,ect laterally a sufficient distance to engage and retain the pads 74 and 76, respectlvely.
In ~hiB instance, the ~lange 84 is arranged to cooperate with the pad 74, and accordingly extends laterally a greater distance than the ~la~ge 86. Moreover~ if de-sired, a series of eetaining spikes 88 can be provided on the retainer 78 to further assist in holding the thicker pad 74.
In order to releasably sec~re the retainer 78 to the body 66J the reta~ner incl~des a pair o~ tabs 90 which cooperate with an L-8haped slot 92 in the ends of the body 66, as can be~t be seen in FIG 5a. To remove the retainer 78 from the dev~ce 64, it is necessary only to press the retainer downwardly and slide it to the le~t, as ind~cated by the arrow 54 in FIG. 5a, thereby releasing the tab 90 from the L portion o~ the slot 92 From this position, the retainer 78 can simply be lifted 11 ~460'~

upwardly out of the cllannel SO, thereby dlsengaging it from the pads 74 and 76 From the foregQing~ it will be appreciated that the iontophoretic treatment apparatus of the present invention provides a device which is self-contained and is easy and convenient to use. Moreover, the device of the invention can be fabricated conveniently and economically, is capable of maintaining a relatively high level of operation over an extended period of time, 10 and may advantageously confine the flow of treatment current to the area of the body being treated.
While several particular forms of the inventlon have been illustrated and described, it will also be apparent that various modifications can be made without departing from the spirit and scope of the lnvention.

Claims (5)

1. A self-contained iontophoretic treatment apparatus comprising: a support structure; a source of electric power and a control means therefor on said support structure for controlling the delivery of said electrical power; a pair of electrodes mounted on said support structure in generally close proximity to one another, said electrodes being connected to said source of electrical power through said control means; porous pads on said electrodes, and an insulating member extending between said electrodes, a first of said electrodes being connected to said source of electrical power and arranged to act primarily as a cathode, and the other electrode being connected to said source of electrical power and arranged to act primarily as an anode, said first electrode being formed of stainless steel and said other electrode being formed of substantially pure aluminum, said support structure and said electrodes being sized and arranged so that a surface to be treated can extend across said insulating member and simultaneously contact both of said pads, whereby electric current from said electrodes for effecting iontophoretic treatment will pass only through the surface being treated.
2. The iontophoretic treatment apparatus as claimed in Claim 1, wherein said porous pads are moisture absorbing; and said insulating member extends between said moisture absorbing pads.
3. The iontophoretic treatment apparatus as claimed in Claim 2, wherein said pads are formed of polyester material.
4. A self-contained iontophoretic treatment apparatus comprising: a support structure; a source of electrical power and a control means on said support structure; a pair of electrodes mounted on a treatment surface of said support structure in generally close proximity to one another, said electrodes being connected to said source of electrical power through said control means; porous pads on said electrodes, and an insulating member extending between said electrodes on said treatment surface, said treatment surface being the upper surface of said support structure and being sized to conform generally with the size of the plantar surface of a human foot, said treatment surface includ-ing a centrally located raised portion along one side thereof to cooperate with the arch portion of said plantar surface of said foot, said insulating member being disposed transversely across said treatment surface between said electrodes so that said plantar surface of said foot to be treated can be placed on said treatment surface extending across said insulating member and simultaneously contact both of said pads, whereby electric current from said electrodes for effecting iontophoretic treatment will pass only through said plantar surface of said foot being treated.
5. A self-contained iontophoretic treatment apparatus comprising: a support structure; a source of electrical power and a control means therefor on said support structure for controlling the delivery of said electrical power; a pair of electrodes mounted on a treatment surface of said support structure in generally close proximity to one another, said electrodes being connected to said source of electric power through said control means; porous pads on said electrodes, and an insulating member extending between said electrodes on said treatment surface, said support structure forming a generally upright housing, said treatment surface including two generally vertical, parallel planes on said housing facing oppositely from one another and the top of said upright housing con-necting said oppositely facing planes, said treatment surface being sized to conform generally with the size of a human axilla, said insulating member being disposed transversely across said treatment surface at the top of said upright housing and between said electrodes so that a human axilla to be treated can extend across said insulating member and simultaneously contact both of said pads, whereby electric current from said electrodes for effecting iontophoretic treatment will pass only through the surface of the axilla being treated.
CA000345403A 1979-11-19 1980-02-11 Iontophoretic treatment apparatus Expired CA1144604A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US095,632 1979-11-19
US06/095,632 US4325367A (en) 1977-06-13 1979-11-19 Iontophoretic treatment apparatus

Publications (1)

Publication Number Publication Date
CA1144604A true CA1144604A (en) 1983-04-12

Family

ID=22252881

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000345403A Expired CA1144604A (en) 1979-11-19 1980-02-11 Iontophoretic treatment apparatus

Country Status (21)

Country Link
US (1) US4325367A (en)
JP (1) JPS5675173A (en)
KR (1) KR830001560B1 (en)
AR (1) AR220815A1 (en)
AT (1) AT374111B (en)
CA (1) CA1144604A (en)
CH (1) CH644524A5 (en)
DE (1) DE3002921A1 (en)
ES (1) ES488468A1 (en)
FI (1) FI64513C (en)
FR (1) FR2469931B1 (en)
GB (1) GB2063072B (en)
HK (1) HK95384A (en)
IE (1) IE49632B1 (en)
IL (1) IL59114A (en)
IT (1) IT1209188B (en)
MX (1) MX149171A (en)
MY (1) MY8500964A (en)
NL (1) NL8000785A (en)
SE (1) SE8000158L (en)
SG (1) SG71884G (en)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981000964A1 (en) * 1979-10-10 1981-04-16 Cyclotech Med Ind Pain blocking bandage
DE3266982D1 (en) * 1981-03-05 1985-11-28 Medtronic Inc Iontophoretic device
US4820263A (en) * 1981-03-06 1989-04-11 Medtronic, Inc. Apparatus and method for iontophoretic drug delivery
JPS5810066A (en) * 1981-07-10 1983-01-20 株式会社アドバンス Plaster structure for ion tofuorese
US4444193A (en) * 1982-01-11 1984-04-24 Medtronic, Inc. Fluid absorbent quantitative test device
US4457748A (en) * 1982-01-11 1984-07-03 Medtronic, Inc. Non-invasive diagnosis method
US4846182A (en) * 1982-01-11 1989-07-11 Medtronic, Inc. Method of preparing a fluid absorbent quantitative test device
JPS58130054A (en) * 1982-01-29 1983-08-03 株式会社アドバンス Plaster structure for iontophoresis
US4557271A (en) * 1983-05-11 1985-12-10 Stoller Kenneth P Method and apparatus for detecting body illness, dysfunction, disease and/or pathology
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US5087240A (en) * 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4883457A (en) * 1983-08-18 1989-11-28 Drug Delivery Systems Inc. Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same
US5605536A (en) * 1983-08-18 1997-02-25 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US5224928A (en) * 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4919648A (en) * 1983-08-18 1990-04-24 Drug Delivery Systems Inc. High tack drug patch
US4921475A (en) * 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5651768A (en) * 1983-08-18 1997-07-29 Drug Delivery Systems, Inc. Transdermal drug applicator and electrodes therefor
IT8312019A0 (en) * 1983-10-18 1983-10-18 Luciano Bacchelli MEANS OF ELECTROTHERAPEUTIC SELF-TREATMENT OF PAIN AND INSOMNIA WITH FIELD ASSOCIATION
US5135477A (en) * 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4706682A (en) * 1985-08-21 1987-11-17 Minnesota Mining And Manufacturing Company External ear canal electrode to be placed proximate the tympanic membrane
AU597890B2 (en) * 1986-03-14 1990-06-14 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US6956032B1 (en) * 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US4725263A (en) * 1986-07-31 1988-02-16 Medtronic, Inc. Programmable constant current source transdermal drug delivery system
JPS63102768A (en) * 1986-10-20 1988-05-07 山之内製薬株式会社 Novel plaster structure for iontophoresis
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4865582A (en) * 1987-06-05 1989-09-12 Drug Delivery Systems Inc. Disposable transdermal drug applicators
WO1989006989A1 (en) * 1988-01-29 1989-08-10 The Regents Of The University Of California Iontophoretic non-invasive sampling or delivery device
US5362307A (en) 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
IL86076A (en) * 1988-04-14 1992-12-01 Inventor S Funding Corp Ltd Transdermal drug delivery device
US4997418A (en) * 1988-04-21 1991-03-05 C. P. Chambers Epidermal iontophoresis device
US5195953A (en) * 1988-04-21 1993-03-23 Demartini Richard J Method of increasing skin absorption of a drug
US5162042A (en) * 1988-07-05 1992-11-10 Alza Corporation Electrotransport transdermal system
US5496266A (en) * 1990-04-30 1996-03-05 Alza Corporation Device and method of iontophoretic drug delivery
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US4979938A (en) * 1989-05-11 1990-12-25 Iomed, Inc. Method of iontophoretically treating acne, furuncles and like skin disorders
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US4950229A (en) * 1989-09-25 1990-08-21 Becton, Dickinson And Company Apparatus for an electrode used for iontophoresis
US5320597A (en) * 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US6004309A (en) 1990-03-30 1999-12-21 Alza Corporation Method and apparatus for controlled environment electrotransport
AU647103B2 (en) * 1990-03-30 1994-03-17 Alza Corporation Iontophoretic delivery device
US5125894A (en) * 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
US5207752A (en) * 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
US5160741A (en) * 1990-07-06 1992-11-03 Alza Corporation Reduction or prevention of skin irritation by drugs
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5149539A (en) * 1990-08-03 1992-09-22 Alza Corporation Reduction or prevention of sensitization to drugs
US6223076B1 (en) * 1990-11-01 2001-04-24 Robert Tapper Sweat control system
US6582416B2 (en) * 1990-11-01 2003-06-24 Robert Tapper Iontophoretic treatment system
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
US5310403A (en) * 1992-05-18 1994-05-10 Becton, Dickinson And Company Iontophoretic drug delivery device and circuit therefor
US5298017A (en) * 1992-12-29 1994-03-29 Alza Corporation Layered electrotransport drug delivery system
US5771890A (en) 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
AU6260896A (en) * 1995-06-06 1996-12-24 Board Of Regents, The University Of Texas System Electrode system in iontophoretic treatment devices
DE69637100T2 (en) * 1995-09-29 2008-01-17 Vyteris, Inc. COST-EFFECTIVE ELECTRODES FOR AN IONTOPHORETIC DEVICE
WO1997014473A1 (en) * 1995-10-18 1997-04-24 Novartis Ag Thermopile powered transdermal drug delivery device
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US6094594A (en) 1996-08-14 2000-07-25 Tapper; Robert Hair removal system
FR2755372B1 (en) 1996-11-07 1998-12-24 Elf Aquitaine IONOPHORESIS DEVICE COMPRISING AT LEAST ONE MEMBRANE ELECTRODE ASSEMBLY FOR THE TRANSCUTANEOUS ADMINISTRATION OF ACTIVE PRINCIPLES TO A SUBJECT
US5939092A (en) * 1997-10-07 1999-08-17 Roggiero; Pablo Composition and method of treatment of anhidrosis in horses
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
US6477410B1 (en) * 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
ATE314114T1 (en) 1999-03-17 2006-01-15 Robert Tapper SWEAT REGULATION SYSTEM
US6512950B2 (en) 2000-02-18 2003-01-28 University Of Utah Research Foundation Methods for delivering agents using alternating current
WO2001060448A1 (en) 2000-02-18 2001-08-23 University Of Utah Research Foundation Methods for extracting substances using alternating current
US6889088B2 (en) * 2000-11-20 2005-05-03 Bassem M. Demian Bunion treating device
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
US7011630B2 (en) * 2001-06-22 2006-03-14 Animas Technologies, Llc Methods for computing rolling analyte measurement values, microprocessors comprising programming to control performance of the methods, and analyte monitoring devices employing the methods
WO2003063950A2 (en) * 2002-02-01 2003-08-07 The Cleveland Clinic Foundation Electrical stimulation to treat hair loss
DE60337038D1 (en) * 2002-03-22 2011-06-16 Animas Technologies Llc Performance improvement of an analyte monitoring device
US20060009730A2 (en) * 2002-07-29 2006-01-12 Eemso, Inc. Iontophoretic Transdermal Delivery of One or More Therapeutic Agents
EP1658228A4 (en) 2003-08-27 2007-07-18 Sang-Kee Kim Container cover
CA2564822A1 (en) * 2004-04-30 2005-11-17 Burrell E. Clawson Apparatus and methods for isolating human body areas for localized cooling
US20080188791A1 (en) * 2007-02-02 2008-08-07 Difiore Attilio E Active iontophoresis delivery system
US8197844B2 (en) * 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
US20090228000A1 (en) * 2008-03-05 2009-09-10 Michael Cao Disposable Apparatus for Patient Grounding
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
EP2320885B1 (en) 2008-06-25 2016-10-19 Fe3 Medical, Inc Patches for the transdermal delivery of a therapeutically effective amount of iron
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
WO2010093472A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010151845A2 (en) * 2009-06-26 2010-12-29 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8903485B2 (en) * 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
WO2012129576A2 (en) 2011-03-24 2012-09-27 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
WO2012154704A2 (en) 2011-05-06 2012-11-15 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
ES1115030Y (en) * 2014-06-25 2014-09-24 Marti Tor Impomedic Sl DEVICE FOR TREATMENT BY IONTOPHORESIS OF SURFACE AREAS OF THE HUMAN BODY
CN105521559A (en) * 2015-09-29 2016-04-27 河南卓安科技有限公司 Intelligent pulse sweating suppression instrument circuit
CN105413055A (en) * 2015-09-29 2016-03-23 河南卓安科技有限公司 Intelligent pulse ion neck and back hidroschesis instrument
CN105435368A (en) * 2015-09-29 2016-03-30 河南卓安科技有限公司 Simple and intelligent pulsed ion antiperspirant instrument
CN105561472A (en) * 2015-09-29 2016-05-11 河南卓安科技有限公司 Intelligent pulse antiperspirant instrument with voice control and use method thereof
CN105435364A (en) * 2015-09-29 2016-03-30 河南卓安科技有限公司 Pulsed ion palmar hyperhidrosis therapeutic apparatus with function of voice control
CN105521558A (en) * 2015-09-29 2016-04-27 河南卓安科技有限公司 Intelligent pulse sweating suppression instrument with load detection function and use method
CN105582614A (en) * 2015-09-29 2016-05-18 河南卓安科技有限公司 Simple wearable portable pulse antiperspirant instrument controlled by APP and usage method thereof
CN105413057A (en) * 2015-09-29 2016-03-23 河南卓安科技有限公司 Intelligent pulse ion armpit hidroschesis instrument
CN105413061A (en) * 2015-09-29 2016-03-23 河南卓安科技有限公司 Intelligent pulse ion face hidroschesis instrument
CN105521560A (en) * 2015-09-29 2016-04-27 河南卓安科技有限公司 APP-controlling wearable portable pulse sweating suppression instrument and use method
CN105435369A (en) * 2015-09-29 2016-03-30 河南卓安科技有限公司 Intelligent pulsed ion antiperspirant instrument with function of load detection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB142585A (en) * 1919-02-27 1920-05-13 William James Panton Improvements in or relating to castors
BE399044A (en) * 1933-09-09
CH171866A (en) * 1933-09-09 1934-09-15 Desider Dr Deutsch Device for introducing remedies into the body by means of lonthophoresis.
US2590876A (en) * 1947-12-20 1952-04-01 Landauer Fred Electrode for electrotherapeutic treatments
BE502972A (en) * 1950-05-03
US2784715A (en) * 1953-03-25 1957-03-12 Kestler Otto Colman Cataphoresis unit
US3472233A (en) * 1966-12-02 1969-10-14 Robert I Sarbacher Electrical muscle stimulator
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4092985A (en) * 1974-11-25 1978-06-06 John George Kaufman Body electrode for electro-medical use
FR2351670A2 (en) * 1976-04-22 1977-12-16 Legoaster Jacqueline Transfer of microorganisms through the skin - by means of an electric current, esp. for treatment of tumours
JPS5244092A (en) * 1975-10-04 1977-04-06 Samy Kogyo Kk Living body ion exchanging device
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4082087A (en) * 1977-02-07 1978-04-04 Isis Medical Instruments Body contact electrode structure for deriving electrical signals due to physiological activity
JPS5647452Y2 (en) * 1977-08-02 1981-11-06
US4177817A (en) * 1978-02-01 1979-12-11 C. R. Bard, Inc. Dual terminal transcutaneous electrode
GB2030453B (en) * 1978-10-03 1983-05-05 Tapper R Applying unidirectional elecric current to the skin of a living body

Also Published As

Publication number Publication date
AR220815A1 (en) 1980-11-28
NL8000785A (en) 1981-06-16
GB2063072A (en) 1981-06-03
CH644524A5 (en) 1984-08-15
KR830001560B1 (en) 1983-08-12
DE3002921A1 (en) 1981-05-27
GB2063072B (en) 1984-02-22
SG71884G (en) 1985-03-29
IL59114A0 (en) 1980-05-30
IE49632B1 (en) 1985-11-13
IT8019832A0 (en) 1980-02-11
DE3002921C2 (en) 1987-11-05
US4325367A (en) 1982-04-20
IT1209188B (en) 1989-07-16
FI800090A (en) 1981-05-20
FI64513C (en) 1983-12-12
AT374111B (en) 1984-03-26
ES488468A1 (en) 1980-10-01
MX149171A (en) 1983-09-14
IE800248L (en) 1981-05-19
FR2469931B1 (en) 1985-07-19
MY8500964A (en) 1985-12-31
FR2469931A1 (en) 1981-05-29
IL59114A (en) 1983-06-15
HK95384A (en) 1984-12-14
JPS6157792B2 (en) 1986-12-08
JPS5675173A (en) 1981-06-22
KR830001653A (en) 1983-05-18
SE8000158L (en) 1981-05-20
FI64513B (en) 1983-08-31
ATA59480A (en) 1983-08-15

Similar Documents

Publication Publication Date Title
CA1144604A (en) Iontophoretic treatment apparatus
US6223076B1 (en) Sweat control system
US4416274A (en) Ion mobility limiting iontophoretic bioelectrode
CA2449554C (en) Electro-acupuncture device with d-shaped stimulation electrodes
US4164226A (en) Iontophoretic burn-protection electrode structure
US4211222A (en) Iontophoretic burn-protection method
EP0140982A1 (en) Insole employing sheet-like battery
JPH02126861A (en) Wound treatment device by electric stimulation
JPH07178185A (en) Muscle electrical stimulating device for passive body training, especially for facial beauty treatment
JP2911876B1 (en) Poultice
JPH1024108A (en) Face covering mask
US4100920A (en) Method and apparatus for transferring microorganisms through the skin barrier
WO2003018116A3 (en) Cold-contact electrode system for iontophoresis
GB2030453A (en) Applying undirectional electric current to the skin of a living body
EP1163025B1 (en) Sweat control system
JP4297401B2 (en) Drug delivery electrode by ion osmosis therapy
JP3044891U (en) Electric bath for bathtub
US20110071491A1 (en) Current Concentration System and Method for Electrokinetic Delivery of Medicaments
SU1512609A1 (en) Apparatus for galvanopuncture
KR910007547B1 (en) Insole employing sheetlike battery
KR850001150B1 (en) Iontohporetic burn-protection electrode structure
EP0447748A1 (en) Device for carrying out an extracorporeal iontophoretic treatment of body parts having a substanially elongated shape
IE47883B1 (en) Apparatus for iontophoresis with iontophoretic burn protection means
RU93039148A (en) THERMOTHERAPEUTIC DEVICE
NL7810249A (en) Iontophoretic burn protection electrode structure - in which one electrode has a porous material on the skin contact side

Legal Events

Date Code Title Description
MKEX Expiry